Drug Trial Radar · NCT00217737
Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
Last checked: Nov 19, 2026Latest source record: Aug 25, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,431
Actual
Start
Sep 6, 2005
Primary completion
Feb 22, 2024
Study completion May 26, 2026
Sponsor
- Lead sponsor
- National Cancer Institute (NCI)NIH
- Sponsor type
- NIH
- First posted
- Sep 22, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This randomized phase III trial studies oxaliplatin, leucovorin, fluorouracil, and bevacizumab to see how well they work compared to oxaliplatin, leucovorin, and fluorouracil in treating patients who have undergone surgery for stage II colon cancer. Drugs used in chemotherapy, such as oxaliplatin, leucovorin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Monoclonal antibodies, such as bevacizumab, may interfere with the ability of tumor cells to grow and spread. It is not yet known whether giving combination chemotherapy together with bevacizumab is more effective than combination chemotherapy alone in treating colon cancer.
Conditions
- Colon Adenocarcinoma
- Stage IIA Colon Cancer AJCC v7
- Stage IIB Colon Cancer AJCC v7
- Stage IIC Colon Cancer AJCC v7
Interventions
BevacizumabBiological
Given IV
FluorouracilDrug
Given IV
LeucovorinDrug
Given IV
OxaliplatinDrug
Given IV
Primary outcomes
What the sponsor says the trial is designed to measure.
- Disease-free Survival Rate at 5 YearsTime frame: Assessed every 3 months for patients within 2 years of step 2 randomization, every 6 months during 3-5 years from step 2 randomization, and then every 12 months until 10 years from step 2 randomization
Locations
928 sites in 5 countries. Site status is shown where the registry gives one.
Northeast Alabama Regional Medical Center
Anniston, Alabama
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama
Clearview Cancer Institute
Huntsville, Alabama
Mobile Infirmary Medical Center
Mobile, Alabama
Providence Hospital
Mobile, Alabama
Providence Alaska Medical Center
Anchorage, Alaska
Mayo Clinic in Arizona
Scottsdale, Arizona
Banner University Medical Center - Tucson
Tucson, Arizona
Mercy Hospital Fort Smith
Fort Smith, Arkansas
NEA Baptist Memorial Hospital
Jonesboro, Arkansas
Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California
Mills-Peninsula Medical Center
Burlingame, California
East Bay Radiation Oncology Center
Castro Valley, California
Eden Hospital Medical Center
Castro Valley, California
Valley Medical Oncology Consultants-Castro Valley
Castro Valley, California
John Muir Medical Center-Concord
Concord, California
City of Hope Comprehensive Cancer Center
Duarte, California
Bay Area Breast Surgeons Inc
Emeryville, California
Valley Medical Oncology Consultants-Fremont
Fremont, California
Washington Health
Fremont, California
Saint Jude Medical Center
Fullerton, California
Glendale Memorial Hospital and Health Center
Glendale, California
Marin Cancer Care Inc
Greenbrae, California
Marin General Hospital
Greenbrae, California
Saint Rose Hospital
Hayward, California
Loma Linda University Medical Center
Loma Linda, California
Veterans Affairs Loma Linda Healthcare System
Loma Linda, California
USC / Norris Comprehensive Cancer Center
Los Angeles, California
Contra Costa Regional Medical Center
Martinez, California
Fremont - Rideout Cancer Center
Marysville, California
Providence Holy Cross Medical Center
Mission Hills, California
Memorial Medical Center
Modesto, California
El Camino Hospital
Mountain View, California
Palo Alto Medical Foundation-Camino Division
Mountain View, California
Sutter Cancer Research Consortium
Novato, California
Wilma Chan Highland Hospital
Oakland, California
Alta Bates Summit Medical Center - Summit Campus
Oakland, California
Bay Area Tumor Institute
Oakland, California
Hematology and Oncology Associates-Oakland
Oakland, California
Showing 40 of 928 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.